Francisco Llinares, autor del excelente libro Manual de instrucciones del cuerpo humano, un naturista que nunca estuvo
enfermo ni se medicó también reconoce que el sida es una macroestafa y un negocio. “Creo que la industria far- macéutica pro- duce muchos más enfermos que los que cura”, comenta Trillo en su libro
Algunos de los libros publicados contra la tesis oficial del sida, aunque difícilmente han llegado
a los canales oficiales de distribución.
Citas. Capítulo ii
Tahi, D. (1996), Vídeo Sida , la duda, op.cit.
Nathan D Wolfe, William M Switzer, Jean K Carr et al (20 March 2004), “Naturally acquired simian retrovirus infections in Central Áfrican Hunters.” The Lancet, Vol. 363, p. 932
http://www.cnn.com/HEALTH/9802/03/earliest.aids/
Fauci, A., (1989), Writing for my sister Denise, The AAAS Observer, Supplement to science, Septem- ber, 1: 4.
http://www.boydgraves.com/flowchart/download.html. http://www.animalweb.cl/noimperial /salud/sida.htm
Siefkes, D. (1993 Oct), “The origin of HIV–1, the AIDS virus”, Med Hypotheses; 41(4):289–99. (http://www.whale.to/vaccines/strecker.html. Crewdson, J,op. cit. p.266. “El laboratorio de Gallo no tenía la capacidad para la producción en masa de virus, pero sus laboratorios contratados sí, y Gallo había estado usando Biotech Research Labs, Electronucleonics and Litton para hacer crecer virus del sida que Popovic llamaba MOV”.
Gottlieb, M. et al. (June 5, 1981 ), “Pneumocystis Pneumonia–Los Angeles,” Morbidity and Mortality
Weekly Report,(vol. 30, pp. 250–52). Goottlieb, M.S., Schorff, R., Schanker, H.M., Weisman, J.D.,
Fan, P.T., Wolf, R.A., (1981 Dec 10), “Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency”. N Engl
J Med.; 305 (24):1425–31. Gottlieb, M.S., (2001 Jun 7), “AIDS–past and future”. N Engl J
Med.;344(23):1788–91. http://www.bosewell.com/NAVersity/AIDS%20
discovery.htm Brown, D., (Tuesday, June 5, 2001), Making Medical History , Twenty Years Ago Today, Doctors First Warned the World of the Emergence of a Deadly New Disease – AIDS , Washington Post ,Staff Writer, Page C01.
http://www.washingtonpost.com/wpdyn/content/article/2006/06/03/. AR2006060300452.html
(10)Trinkaus, G., (1998), How the chronicle invented AIDS op. cit. www.whatitisaids.com/howthechro-
ninventedaids.htm.
Crewdson,J, (19 November 1989), “The great AIDS quest”, Chicago Tribune. http://www.virusmyth.net/aids/data/srlabrat.htm http://history.nih.gov/NIHInOwnWords/docs/ Levine.htm.
http://www.tetrahedron.org/articles/aids–coverups/Vaccine_Induced_Pandemic.html. Horowitz, L.G., D.M.D., M.A., M.P.H., “(29–05– 2001), “Hepatitis B Vaccine and the Origin of HIV/AIDS: Pers- pectives on a Possible Vaccine Induced Pandemic”.
(November 4, 1996), “AIDS’ Achilles’ heel?” Newsweek,. Samaniego, F., et al. (January 20, 1999.), “Induction of programmed cell death in Kaposi’s sarcoma cells by preparations of human chorionic gonadotropin.” J. National Cáncer Institute 91(2):135 – 143, Janeway, et al., (2005), Immunobiology. 6th ed., Garland Science,. ISBN 0815341016. NCBI makes the 5th edition available electronically at Ross, M.H. et al. (2003),.Histology: A Text and Atlas, 4th ed., Lippincott Williams & Wilkins. Vozelj, M., (2005), Temelji imunologije, 1th ed., DZS, Ljubljana, Slovenia.
http://www.garynull.com/Documents/Continuum/InterviewNoamChomski.htm. Continuum Magazine, VOL. 4 Nº. 3 ,Questions by Huw Christie, Rafael Ramos and Michael U. Baumgartner.
http://free–news.org/JGB_al_Fiscal_dic2001.htm http://www.lewrockwell.com/orig7/culshaw1.html Gottlieb, M. op. cit.
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16)
Sonnanbend, J.A., (1989), AIDS FORUM, vol 2, nº1.
Duesberg, P.H, (1989), “Human inmunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation”. Pro. Nant. Acad. Sci, USA, 86: 755–764. Stutman, O., (1975), “Immu- nodepression and malignancy”, Adv. Cáncer res., 22: 261–422.
http://www3.dermis.net/dermisroot/es/17313/diagnose.htm
Friedman–Kien AE, Saltzman BR, Cao YZ, et al (1990).” Kaposi’s sarcoma in HIV–negative homo- sexual men”. Lancet 335 (8682): 168–9.
Safai B, (1997), (Kaposi’s sarcoma and acquired immunodeficiency syndrome. In: DeVita VT, Hell- man S, Rosenberg S, eds.: AIDS: Etiology, Diagnosis, Treatment and Prevention. 4th ed. Philadelphia, Pa: Lippincott–Raven Publishers, pp 295–318.
Chang Y, Cesarman E, Pessin MS, et al (1994), “Identification of herpesvirus–like DNA sequences in AIDS–associated Kaposi’s sarcoma”. Science 266 (5192): 1865–9.
Moore PS, Chang Y, (1995), “ Detection of herpesvirus–like DNA sequences in Kaposi’s sarcoma in patients with and without HIV infection”. N Engl J Med 332 (18): 1181–5.
Krigel RL, Laubenstein LJ, Muggia FM, (1983), “ Kaposi’s sarcoma: a new staging classification”.
Cáncer Treat Rep67 (6): 531–4.
Gill PS, Akil B, Colletti P, et al. (1989), “Pulmonary Kaposi’s sarcoma: clinical findings and results of therapy”,. Am J Med 87 (1): 57–61.
Su IJ, Hsu YS, Chang YC, et al. ( 1995), “Herpesvirus–like DNA sequence in Kaposi’s sarcoma from AIDS and non–AIDS patients in Taiwan”. Lancet 345 (8951): 722–3.
Gao SJ, Kingsley L, Li M, et al. (1996), “ KSHV antibodies among Americans, Italians and Ugan- dans with and without Kaposi’s sarcoma”. Nat Med 2 (8): 925–8.
Chang Y, Ziegler J, Wabinga H, et al.(1996), “ Kaposi’s sarcoma–associated herpesvirus and Kapo- si’s sarcoma in África. Uganda Kaposi’s Sarcoma Study Group”. Arch Intern Med 156 (2): 202–4. Safai B, Good RA, (1980), “Kaposi’s sarcoma: a review and recent developments”. Clin Bull 10 (2): 62–9. Reynolds WA, Winkelmann RK, Soule EH, (1965), “ Kaposi’s sarcoma: a clinicopathologic study with particular reference to its relationship to the reticuloendothelial system” Medicine (Balti- more) 44 (5): 419–43.
Safai B, Miké V, Giraldo G, et al.(1980), “ Association of Kaposi’s sarcoma with second primary malignancies: possible etiopathogenic implications”. Cáncer 45 (6): 1472–9.
Taylor JF, Templeton AC, Vogel CL, et al (1971), “ Kaposi’s sarcoma in Uganda: a clinico–patholo- gical study”. Int J Cáncer 8 (1): 122–35.
Templeton AC, Bhana D, (1975), “ Prognosis in Kaposi’s sarcoma”. J Natl Cáncer Inst 55 (6): 1301–4. Penn I: (1979), Kaposi’s sarcoma in organ transplant recipients: report of 20 cases. Transplantation 27 (1): 8–11.
Vogel J, Hinrichs SH, Reynolds RK, et al.(1988), “The HIV tat gene induces dermal lesions resem- bling Kaposi’s sarcoma in transgenic mice”. Nature 335 (6191): 606–11, 1988. Cree que el gen TAT del VIH puede causar indirectamente el Sarkoma de Kaposi.
Selik RM, Starcher ET, Curran JW, (1987), “Opportunistic diseases reported in AIDS patients: fre- quencies, associations, and trends”. AIDS 1 (3): 175–82.
CDC(1981), “Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men–New York City and California”. MMWR Morb Mortal Wkly Rep 30 (25): 305–8.
Quinn TC, Mann JM, Curran JW, Piot P (1986), “AIDS in África: An Epidemiologic Paradigm”, Science, 1986, 234: 955–963.
Carta deNoN M. Sarngadharan al OSI, Febrero 29, 1991; Crewdson, J. (2002), op.cit. p. 123; Kuls- tad, R. M., (1996), “Publishing AIDS papers.” In AIDS and the Public Debate: Historical and Contem-
porary Perspectives. Burke, VA: IOS Press.
(October 6, 1986.) “Disputed territory.” New York Native. Crewdson, J, (2002), op. cit. p. 621.
http://www.meta–religion.com/Secret_societies/Conspiracies/AIDS/secret_origin_of_aids.htm. The Secret Origin of AIDS & HIV ,by ALAN CANTWELL JR., MD. –Con ciertas dosis de ciencia ficción, el dr. Cantwell sostiene que el sida es un virus genocida creado en el laboratorio.
Butel JS (2000), “ Simian virus 40, poliovirus vaccines, and human cáncer: research progress versus media and public interests”, Bulletin World Health Organization, 78:195–198.
Gallo R., (1991), Virus Hunting: AIDS, Cáncer and the Human Retrovirus. New York: Basic Books. Hoo-
Citas. Capitulo II (17) (18) (19) (20) (21) (22) (23) (24)
per E, (2000), The River: A Journey to the Source of HIV and AIDS. Boston, MA: Little, Brown & Com- pany, 1999 1997, pp 28–35.
Crewdson, J, (2002), op. cit. p. 133. Crewdson, J, (2002) , op. cit. p. 141. Crewdson, J, (2002), op. cit. p. 137.
Herbert PC, Wells G, Tweedale M, et al. (1997), “Does Transfusion Practice Affect Mortality in Cri- tically Ill Patients? “, Am J Respir Crit Care Med ; 155: 1618–1623. Herbert, P. Et al, Blood transfu- sions: fewer Blood transfusions save lives, New England Journal of Medicine (NEJM), 11–02–1999 Crewdson, J, (2002), op. cit. pp. 39 y 143.
Crewdson, J, (2002), op. cit. p. 148. Crewdson, J, (2002), op. cit. p. 148. Crewdson, J, (2002), op. cit. pp. 342 y ss.
Duesberg, PH (1992) , “AIDS acquired by drug consumption and other noncontagious risk factors” , Pharmac. Ther. 55: 201–277.
El diario de Gardner muestra que el encuentro tuvo lugar el viernes 2 de noviembre de 1984.(Crewd- son, 2002)
Carta de M.Gardner to J. Levy, 30 de Octubre de 1984, desde el California Primate Research Cen- ter de Davis, California.
http://www.sciencefictions.net/pdfdocs/Letter_from_M_Gardner_to_J_Levy_10.30.84.pdf. M. Martin to The Record, November 9, 1984; Crewdson, J. (November 19 1989), “The Great AIDS Quest.” Chicago Tribune.
Ratner, L., et al (January 24 1985), “Complete nucleotide sequence of the AIDS virus, HTLV–3.”
Nature313:277.
Muesing M.A., et al. (February 11 1985), “Nucleic acid structure and expression of the human AIDS/lymphadenopathy.” Nature 313:450.
Crewdson, J. (2002), op. cit. p. 166 y ss.
Wain–Hobson, S., et al, ( January 21, 1985).,“Nucleotide sequence of the AIDS virus, LAV.” Cell 40:9 – 17.
Crewdson, J, (2002), op .cit. p. 249. Crewdson, J, (2002), op. cit. p. 158.
Voluntary Separation and Property Settlement Agreement between Stephen Staal and Flossie Wong–Staal. Filed April 23, 1985, Montgomery County, Maryland.
Maggiore,C.(2001), op. cit.
Montagnier, L. (2002), “A history of HIV discovery”, Science, 29–11–, vol. 298, p. 1728. Tahi, D. (1996), Sida, la duda, vídeo documental.
Ho, D., (2005), “ A Shot in the Arm for AIDS Vaccine Research”, PLoS Med.; 2(2): e 36. Published online 2005 January 18. doi: 10.1371/journal.pmed.0020036.
Duesberg, PH (1992), “ AIDS acquired by drug consumption and other noncontagious risk factors”,
Pharmac. Ther.55: 201–277. p. 161.
EPS (El País Semanal), (30 julio 2006), Entrevista Pere–Joan Cardona, investigador de la tuberculo-
sis, p. 12. Los estudios de la vacuna para la tuberculosis de Cardona investigador del hospital Can Ruti son tan sospechosos y discutibels como los del sida. El hospital Can Ruti es uno de los centros oficialistas más dogmáticos.
“Un informe alerta de la expansión de una cepa resistente de la tuberculosis”, titular de El Mundo.es,
Salud, 21/08/2006.
http://www.el–mundo.es/salud/2000/393/961655007.html.
Matey,P. (24–06–2006), “Enfermedades antes curables se han vuelto difíciles de tratar”, El Mundo.es,
Suplemento Salud, número 393.
Abinzano ML, Velilla JP, Elejalde I, Perez C, Michelena I, Pruja E, Rubio T. L, (1997 May–Aug), “Vis- ceral leishmaniasis in the immunocompetent patient”, An Sist Sanit Navar.; 20(2):231–4.
Bhateja P, Mathur T, Pandya M, Fatma T, Rattan Ashok , (2005), “Detection of vancomycin resistant
Staphylococcus aureus: A comparative study of three different phenotypic screening methods”, Indian Journal of Medical Microbiologyvol. 23, nº1, pp. 52 y 55. Department of Microbiology, Ranbaxy
Research Laboratories, R&D II, Sector 18, Udyog Vihar Industrial Area, Gurgaon–122 001, Haryana, India Jamia Millia Islamia University, New Delhi, India.
Carta de R. Gallo a J. Maddox, (May 20, 1992).
La macroestafa del SIDA
(25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48)
Lusso, P., and Gallo, R. C.(March 5, 1994), “Human herpesvirus 6 in AIDS.” Lancet 343:555, Saxinger, C., et al. (May 25, 1988), “Antibody reactivity with HBLV (HHV–6) in U.S. populations.”
J. Virol. Methods21:199 – 208.
Downing, R. G., et al. (1987), “Isolation of human lymphotropic herpesvirus from Uganda. Lancet ii: 390 ; Tedder, R. S., et al.(1987), “A novel lymphotropic herpesvirus.” Lancet ii: 390.
Ablashi, D. V., et al. (June 1 – 5, 1987), “Presence of human B–lymphotropic virus (HBLV) antibody in sera from infected AIDS patients.” Kaplan, M. H. et al. “Antibody reactions to human B cell lympho- tropic virus (HBLV) in HIV infection.” III International Conference on AIDS, Washington, D.C.
Washington Post, November 24, 1986. Lancet, 1990 Feb 10;335(8685):325–6.
Crewdson, 2002, op.cit. pp. 534 y ss.
(November 8, 1994.), “New techniques hold promise in fighting AIDS”, New York Times. Varmus, H. “AIDS: The process of discovery.” Science 275:140–44. January 10, 1997.
Artículo de Fauci & Longo dentro del manual de Harrison, (2005), Principios de Medicina Interna, McGraw–Hill , p.1190.
Crewdson, J, 2002, op.cit. p. 343.
http://la.indymedia.org/print.php?id=69791. Crewdson, J. (2002), op. cit.
Vigilancia epidemiológica del sida en España. Registro Nacional de Casos de sida. Actualización a 30 de junio de 2005. Informe SemestraL nº 1, año, 2005, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo. Datos del Registro Nacional de Sida y entrevista personal de Luis Carlos Campos a la dra. Lourdes Chamorro (2006), responsable del Plan Nacional de Sida.
todocáncer.org. http://cne.isciii.es/htdocs/cardiov/isquemica/tabla5IAM.htm.
Vigilancia epidemiológica del sida en España, registro nacional de casos de sida, actualización a 30 de junio de 2005, informe semestral nº 1, año 2005, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo.
Datos del Instituto Nacional de Estadística (INE) y de la Sociedad americana contra el Cáncer (ACS). E. de B. (19–02–06 ), “Las muertes por cáncer bajan por primera vez en Estados Unidos”, El País, sociedad, p.13. http://www.isciii.es/htdocs/centros/epidemiologia/epi_enfcardio_tabla1.jsp. http://www.nutrar.com/detalle.asp?ID=861 diabetes. Citas. Capitulo II (49) (50) (51) (52) (53) (54) (54) (55) (56) (57)